Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells

3 Biotech 2026 Open access

Read full text
Authors: Chinmay Das, Subarno Paul, Subhasmita Bhal, Sushree Subhadra Acharya, Somya Ranjan Dash, Aakash Goswami, Aashi Thakur, Pramod Chandra Pathy, Chanakya Nath Kundu, Tithi Parija
DOI: 10.1007/s13205-025-04670-2
Cited by: 1
References: 51

Fields of Study & Subjects

PARP inhibition in cancer therapy Lung Cancer Research Studies Advanced Breast Cancer Therapies

Publication details

Journal / source
3 Biotech
Publisher
Springer Science and Business Media LLC
Volume
16
Issue
1
Pages
49–49
Publication date
1 January 2026
Language
EN